From the Food and Drug Administration.
Nightingale
S L
SL
D000293:Adolescent; D000328:Adult; D000329:Advertising / Q000331:legislation & jurisprudence*; D001546:Bentonite / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D011040:Dermatitis, Toxicodendron / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D017277:Drug Approval; D004348:Drug Labeling / Q000592:standards*; D011307:Drug Prescriptions / Q000592:standards*; D006801:Humans; D044469:Racial Groups; D000074606:Smoking Prevention; D019460:Tobacco Industry / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration
D003879:Dermatologic Agents; D001546:Bentonite; C006691:bentoquatam